AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding AC Immune SA changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 32 | 37 | +5 |
| Shares | 29.6M | 29.0M | −674.2K (−2.3%) |
| Value | $148.2M | $85.7M | −$62.5M (−42.1%) |
New holders (10)
Institutions that held AC Immune SA at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Landscape Capital Management, L.L.C. | 117,418 | $347.6K | 0.03% |
| Scoggin Management LP | 84,401 | $249.8K | 0.19% |
| Citadel Advisors LLC | 60,732 | $179.8K | 0.00% |
| Jane Street Group, LLC | 14,418 | $42.7K | 0.00% |
| XTX Topco Ltd | 11,644 | $34.5K | 0.00% |
| Lazard Asset Management LLC | 10,260 | $30.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,919 | $11.6K | 0.00% |
| Group One Trading, L.P. | 451 | $1.33K | 0.00% |
| Simplex Trading, LLC | 635 | $1.00K | 0.00% |
| Qube Research & Technologies Ltd | 48 | $142 | 0.00% |
Sold out (5)
Institutions that held AC Immune SA at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| StemPoint Capital LP | 434,588 | $2.17M |
| Nixon Peabody Trust Co | 12,850 | $64.3K |
| Virtu Financial LLC | 11,552 | $58.0K |
| Edmond de Rothschild Holding S.A. | 2,000 | $10.0K |
| Advisor Group Holdings, Inc. | 2,000 | $10.0K |